A hierarchical approach in the diagnostic workflow of chronic myelomonocytic leukemia: Pivotal role of the "Mono-dysplasia-score" combined with flow cytometric quantification of monocyte subsets.
Abstract
INTRODUCTION: Monocytosis is a frequent trigger for blood smear review in a routine hematology laboratory whereas chronic myelomonocytic leukemia (CMML) is infrequent and arises mostly in elderly patients. In order to define the best workflow for monocytosis, we studied three diagnostic approaches: the classical morphology approach (blood smear review), the flow cytometry assay (quantification of monocyte subsets as described by Selimoglu-Buet et al in 2015), and the "mono-dysplasia-score" also referred to as "Monoscore (as described by our team in 2018 using the structural parameters of the Sysmex XN™ analyzers). METHODS: Studying a multicentric cohort of 196 nonclonal monocytoses and CMML patients aged over 50 years, we compared the diagnostic performance of the three approaches alone and in combination to propose a diagnostic decision tree. RESULTS: In patients presenting with additional criteria for slide review to monocytosis (37% of our cohort), we propose to sequentially combine morphology, Monoscore, and flow cytometry. On the contrary, for patients with isolated monocytosis (63%), slide review is not mandatory and we suggest performing flow cytometry depending on the Monoscore value. Using the proposed algorithm, 98% of CMML patients would have been correctly identified, slide review rate drastically reduced, and flow cytometry would have been carried out in 44% of patients. CONCLUSION: We have shown that implementation of Monoscore is a useful input filter to significantly reduce slide reviews without losing sensitivity and that flow cytometry is a performant technique in the second step of the diagnostic workup of CMML.
Related
- OA05 Complex polyostotic fibrous dysplasia in McCune-Albright syndrome: diagnostic and management challenges
- Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.
- Case Report: Chronic myelomonocytic leukemia with mature plasmacytoid dendritic cell proliferation initially classified as MDS-IB2
- Flow Cytometric Detection of Bone Marrow Cell Populations Phenotypically Compatible with Neuroblastoma: An Exploratory Comparison with Conventional Methods
- Prognostic implications of TET2 variant allele frequency in chronic myelomonocytic leukemia: a multicenter study.
BibTeX
@article{clauser2026hierarchical,
title = {{A hierarchical approach in the diagnostic workflow of chronic myelomonocytic leukemia: Pivotal role of the "Mono-dysplasia-score" combined with flow cytometric quantification of monocyte subsets.}},
author = {Clauser S and Maillon A and Capron C and Jondeau K and Ronez E and Schillinger F and Garnache-Ottou F and Cornet E and Valérie Bardet and Zhu J and Sourdeau E and Aubert H},
journal = {International Journal of Laboratory Hematology},
year = {2026},
month = oct,
doi = {10.1111/ijlh.13115},
url = {https://hal.science/hal-05785527v1},
note = {CC BY},
}
RIS
TY - JOUR
TI - A hierarchical approach in the diagnostic workflow of chronic myelomonocytic leukemia: Pivotal role of the "Mono-dysplasia-score" combined with flow cytometric quantification of monocyte subsets.
AU - Clauser S
AU - Maillon A
AU - Capron C
AU - Jondeau K
AU - Ronez E
AU - Schillinger F
AU - Garnache-Ottou F
AU - Cornet E
AU - Valérie Bardet
AU - Zhu J
AU - Sourdeau E
AU - Aubert H
PY - 2026
DA - 2026/10/08
JO - International Journal of Laboratory Hematology
DO - 10.1111/ijlh.13115
UR - https://hal.science/hal-05785527v1
AB - INTRODUCTION: Monocytosis is a frequent trigger for blood smear review in a routine hematology laboratory whereas chronic myelomonocytic leukemia (CMML) is infrequent and arises mostly in elderly patients. In order to define the best workflow for monocytosis, we studied three diagnostic approaches: the classical morphology approach (blood smear review), the flow cytometry assay (quantification of monocyte subsets as described by Selimoglu-Buet et al in 2015), and the "mono-dysplasia-score" also referred to as "Monoscore (as described by our team in 2018 using the structural parameters of the Sysmex XN™ analyzers). METHODS: Studying a multicentric cohort of 196 nonclonal monocytoses and CMML patients aged over 50 years, we compared the diagnostic performance of the three approaches alone and in combination to propose a diagnostic decision tree. RESULTS: In patients presenting with additional criteria for slide review to monocytosis (37% of our cohort), we propose to sequentially combine morphology, Monoscore, and flow cytometry. On the contrary, for patients with isolated monocytosis (63%), slide review is not mandatory and we suggest performing flow cytometry depending on the Monoscore value. Using the proposed algorithm, 98% of CMML patients would have been correctly identified, slide review rate drastically reduced, and flow cytometry would have been carried out in 44% of patients. CONCLUSION: We have shown that implementation of Monoscore is a useful input filter to significantly reduce slide reviews without losing sensitivity and that flow cytometry is a performant technique in the second step of the diagnostic workup of CMML.
SN - 1751-5521
SN - 1365-2257
ER -